{"entities": {"annotations": [{"start": 0, "end": 5, "probability": 0.391, "type": "Organization", "normalized_text": "Gilead"}], "urls": [{"start": 122, "end": 145, "url": "https://t.co/5eiiHQgDLS", "expanded_url": "https://reut.rs/2y0tQ2E", "display_url": "reut.rs/2y0tQ2E"}]}, "text": "Gilead said its experimental antiviral drug, remdesivir, had met the main goal of a trial testing it in COVID-19 patients https://t.co/5eiiHQgDLS", "public_metrics": {"retweet_count": 469, "reply_count": 73, "like_count": 780, "quote_count": 181}, "lang": "en", "conversation_id": "1255482228450222085", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "46", "name": "Brand Category", "description": "Categories within Brand Verticals that narrow down the scope of Brands"}, "entity": {"id": "781974596157181956", "name": "Online Site"}}, {"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "10047963346", "name": "Reuters", "description": "Reuters"}}], "created_at": "2020-04-29T13:01:03.000Z", "id": "1255482228450222085", "author_id": "1652541", "reply_settings": "everyone", "source": "SocialFlow", "possibly_sensitive": false}